Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by JamesJackon Apr 27, 2017 9:16am

148 Views

Post# 26172964

RE:RE:RE:RE:RE:RE:RE:RE:RE:6.79

jfm1330 wrote: Sorry, I know they will file one day, maybe tomorow or Monday. That being said they were wrong many times on the timelines they gave. It was first supposed to be in 2016, then in Q1 2017, then end of March 2017, then around the end of March, then two to three weeks at most, and the last version is end of April and we are one day away from it. I don't really complain because the SP is rising, but it is clear they are not champions at meeting their own deadlines.

Will they announce they have finished BLA filing? Is it mandatory to do it? Is there any example of this kind of announcement?

Bullboard Posts

Nextech CEO provides company update on Amazon deal and more